Percutaneous Minimally Invasive Partial Resection of Vertebral Lesions Combined with Decompression and Percutaneous Vertebroplasty Injection for Thoracolumbar Metastatic Tumors
Bone and Arthrosurgery Science · 11.03.2026 · 4 (1) · 47-54
DOI: 10.26689/bas.v4i1.14147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone and Arthrosurgery Science, online erschienen am 11.03.2026. Verfasst von Yufei Wang und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To explore the clinical efficacy and safety of percutaneous minimally invasive partial resection of vertebral lesions combined with decompression and percutaneous vertebroplasty (PVP) in the treatment of thoracolumbar metastatic tumors.
Methods
The clinical data of 54 patients with thoracolumbar metastatic tumors who underwent percutaneous minimally invasive partial resection of vertebral lesions combined with decompression and PVP injection in our hospital from January 2020 to June 2024 were analyzed retrospectively. All patients received local anesthesia. There were 27 males and 27 females, including 31 cases of thoracic vertebral metastases, 18 cases of lumbar vertebral metastases, and 5 cases of thoracolumbar vertebral metastases. The Visual Analog Scale (VAS) score for pain and Oswestry Disability Index (ODI) before surgery and 1 week after surgery were compared. Meanwhile, the operation time, intraoperative blood loss, bone cement leakage, and other complications were recorded.
Results
All patients successfully completed the operation. The operation time was 45–90 (67.89 ± 11.96) minutes, and the intraoperative blood loss was 30–100 (60.19 ± 20.16) mL. All patients were followed up for 3–12 months, with an average of 7.8 months. Except for 5 patients who experienced bone cement leakage, all other patients had their lesions healed smoothly, with no intraspinal leakage or other complications. The preoperative VAS score was 6–9 (7.69 ± 1.03) points, and the ODI was 51–79% (74.70 ± 7.64)%. One week after surgery, the VAS score was 1–3 (2.07 ± 0.70) points, which was significantly improved compared with that before surgery (P < 0.05). One week after surgery, the ODI was 24–41% (31.93 ± 4.43)%, which was also significantly improved compared with that before surgery (P < 0.05).
Conclusion
Percutaneous minimally invasive partial resection of vertebral lesions combined with decompression and PVP injection in the treatment of thoracolumbar metastatic tumors has the advantages of minimal invasiveness, effective relief of cancer-related pain, restoration of vertebral stability, and few complications, which is conducive to improving the quality of life of patients.
Zitieren
APA
Wang, Y., Jiang, W., Xu, J., Qin, C., Wang, X., Deng, H., & Ma, Y. (2026). Percutaneous Minimally Invasive Partial Resection of Vertebral Lesions Combined with Decompression and Percutaneous Vertebroplasty Injection for Thoracolumbar Metastatic Tumors. Bone and Arthrosurgery Science, 4(1), 47-54. https://doi.org/10.26689/bas.v4i1.14147
Vancouver
Wang Y, Jiang W, Xu J, Qin C, Wang X, Deng H, et al. Percutaneous Minimally Invasive Partial Resection of Vertebral Lesions Combined with Decompression and Percutaneous Vertebroplasty Injection for Thoracolumbar Metastatic Tumors. Bone and Arthrosurgery Science. 2026;4(1):47-54. doi:10.26689/bas.v4i1.14147
BibTeX
@article{Wang2026,
author = {Wang, Yufei and Jiang, Wenkai and Xu, Jun and Qin, Congcong and Wang, Xinrui and Deng, Hongfei and Ma, Yaobin},
title = {Percutaneous Minimally Invasive Partial Resection of Vertebral Lesions Combined with Decompression and Percutaneous Vertebroplasty Injection for Thoracolumbar Metastatic Tumors},
journal = {Bone and Arthrosurgery Science},
year = {2026},
volume = {4},
number = {1},
pages = {47--54},
doi = {10.26689/bas.v4i1.14147}
}
EUVIMED